Shutong Technologies Invites You to the 2nd China Cell & Gene Therapy Congress (CSGCT 2025)

Sep 10, 2025 15:45 CST Updated 15:46

China is transitioning from a global“Followers” in the CGT sector are rapidly evolving into “peers” and even “front-runners,” as a dynamic and high-potential Chinese CGT industrial ecosystem accelerates its formation, contributing increasingly significant “Chinese solutions” and “Chinese wisdom” to global health endeavors.

Conference Highlights:

1 Main Forum + 15 Sub-forums
10+CGTInternational Leader
50+MNCClinicalPI
500+Investor/Investment Institutions
3000+Elites and Professional Attendees in the Field of Cell and Gene Therapy

At this critical juncture, resonating in sync with the national and local strategies against the backdrop of the current era,The 2nd China Cell & Gene Therapy (CSGCT) Congress 2025Shouldemerged and will beSeptember 12–13, 2025Grandly unveiled at the Exhibition and Trading Center of Zhongguancun National Independent Innovation Demonstration Zone.

This Conference2025CSGCT Conference with“Regulatory Foundation, Collective Wisdom, Global Connectivity, Shared Future”Centered on this core philosophy, the event features five major segments: “Forum + Roadshow + Exhibition + Awards + In-depth Site Visits,” aiming to build an authoritative, open, and efficient global dialogue platform. This enables key stakeholders in the cell and gene therapy (CGT) industry—including policymakers, scientists, clinicians, entrepreneurs, and investors—to engage in deep exchanges of ideas, spark intellectual synergy, and explore collaborative opportunities.

At that time,Shutong Technologywill carryOne-Stop Platform for Gene Editing Safety AssessmentWe sincerely invite and welcome experts and scholars to attend the conference. B09# ExhibitionPositionengage in communication.

Meeting Information

Time:September 12-13, 2025

Location:Beijing-Zhongguancun National Independent Innovation Demonstration Zone

Report Information

Report 1:

Advances in Vector Integration Site Detection and Regulatory Requirements

Speaker

Yu XiaoyingZhuhai Shutong Medical Technology Co., Ltd., Head of High-Throughput Sequencing Laboratory

Report Time

September 12 15:35-16:00

Report Location

A105 Jingming Hall- Subforum 4 | Breakthrough Advances in Immune Cell Therapy for Autoimmune Diseases

Report 2:

Safety Assessment of Gene Therapy: Evolution of Regulatory Science and Best Practices

Speaker

Tian Rui Zhuhai Shutong Medical Technology Co., Ltd., CTO

Report Time

September 13 09:40-10:00

Report Location

A101 Yihe Hall- Subforum 13 | Latest Requirements and Technologies for Quality Control and Testing of CGT Products in Various Countries

About Shu Tong

Zhuhai Shutong Medical Technology Co., Ltd. is a biopharmaceutical enterprise with gene editing as its core technology. Headquartered in the Hengqin New Area of the Guangdong-Macao In-Depth Cooperation Zone, the company has established wholly-owned subsidiaries, including Gurun (Wuhan) Medical Technology Co., Ltd., Guangzhou Shutong Medical Technology Co., Ltd., and Hangzhou Shutong Biotechnology Co., Ltd. Recognized as a National High-Tech Enterprise, the company operates a postdoctoral workstation with multiple postdoctoral research teams, has filed more than 40 patent applications, and has undertaken several major national science and technology special projects. Dedicated to developing novel therapeutics for various diseases, particularly tumors, through innovative technologies, the company provides gene-targeted treatment solutions. Meanwhile, the company has builtOne-Stop Gene Editing Platform, Molecular Diagnostics Platform, and Technology Services Platform，We offer end-to-end solutions spanning target screening, gene editing efficacy testing, and safety assessment.; Possessing advanced large-scale production capabilities for CGT raw materials, it provides safe and efficient one-stop services and material supply to research institutions and biopharmaceutical companies. Adhering to the core values of “Innovation, Dedication, Integration, and Openness,” Shutong Medical is committed to leveraging gene therapy technologies to benefit human health and make life better.

For more information, please contact us:

Tel:

400-6309596

18437963580 (WeChat ID)

Corporate Website:

www.generulor.com.cn

Product Ordering/Technical Support:

service@generulor.com